HEADER TRANSFERASE/TRANSFERASE INHIBITOR 13-MAR-15 4YQV TITLE GLUTATHIONE S-TRANSFERASE OMEGA 1 BOUND TO COVALENT INHIBITOR C4-10 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTATHIONE S-TRANSFERASE OMEGA-1; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: GSTO-1,GLUTATHIONE S-TRANSFERASE OMEGA 1-1,GSTO 1-1, COMPND 5 GLUTATHIONE-DEPENDENT DEHYDROASCORBATE REDUCTASE,MONOMETHYLARSONIC COMPND 6 ACID REDUCTASE,MMA(V) REDUCTASE,S-(PHENACYL)GLUTATHIONE REDUCTASE, COMPND 7 SPG-R; COMPND 8 EC: 2.5.1.18,1.8.5.1,1.20.4.2; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GSTO1, GSTTLP28; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA2 KEYWDS COVALENT INHIBITOR, THIOLTRANSFERASE, CHLOROACETAMIDE, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.A.STUCKEY REVDAT 3 27-SEP-23 4YQV 1 REMARK REVDAT 2 19-OCT-16 4YQV 1 JRNL REVDAT 1 12-OCT-16 4YQV 0 JRNL AUTH K.RAMKUMAR,S.SAMANTA,A.KYANI,S.YANG,S.TAMURA,E.ZIEMKE, JRNL AUTH 2 J.A.STUCKEY,S.LI,K.CHINNASWAMY,H.OTAKE,B.DEBNATH, JRNL AUTH 3 V.YAROVENKO,J.S.SEBOLT-LEOPOLD,M.LJUNGMAN,N.NEAMATI JRNL TITL MECHANISTIC EVALUATION AND TRANSCRIPTIONAL SIGNATURE OF A JRNL TITL 2 GLUTATHIONE S-TRANSFERASE OMEGA 1 INHIBITOR. JRNL REF NAT COMMUN V. 7 13084 2016 JRNL REFN ESSN 2041-1723 JRNL PMID 27703239 JRNL DOI 10.1038/NCOMMS13084 REMARK 2 REMARK 2 RESOLUTION. 2.06 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.06 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 46430 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 2345 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.06 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.11 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 62.11 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2238 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2160 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2131 REMARK 3 BIN R VALUE (WORKING SET) : 0.2130 REMARK 3 BIN FREE R VALUE : 0.2660 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.78 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 107 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5604 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 51 REMARK 3 SOLVENT ATOMS : 405 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.88920 REMARK 3 B22 (A**2) : 2.33250 REMARK 3 B33 (A**2) : -1.44330 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 7.64560 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.260 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.217 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.166 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.213 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.166 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.922 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5812 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7875 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2650 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 137 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 873 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5812 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 733 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7058 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 0.92 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.83 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.75 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: {A|5 - 241} REMARK 3 ORIGIN FOR THE GROUP (A): 5.6370 -11.2144 24.7660 REMARK 3 T TENSOR REMARK 3 T11: -0.0717 T22: -0.1026 REMARK 3 T33: -0.0894 T12: 0.0119 REMARK 3 T13: -0.0306 T23: 0.0117 REMARK 3 L TENSOR REMARK 3 L11: 1.4884 L22: 1.5609 REMARK 3 L33: 2.0926 L12: -0.3698 REMARK 3 L13: -0.2769 L23: 0.2881 REMARK 3 S TENSOR REMARK 3 S11: -0.0171 S12: 0.0589 S13: 0.0747 REMARK 3 S21: 0.0139 S22: 0.0213 S23: -0.1471 REMARK 3 S31: 0.2174 S32: 0.2242 S33: -0.0042 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: {B|5 - 241} REMARK 3 ORIGIN FOR THE GROUP (A): 20.0852 22.5042 -3.7386 REMARK 3 T TENSOR REMARK 3 T11: -0.0751 T22: -0.0980 REMARK 3 T33: -0.1013 T12: -0.0033 REMARK 3 T13: 0.0104 T23: -0.0641 REMARK 3 L TENSOR REMARK 3 L11: 2.0595 L22: 2.0531 REMARK 3 L33: 1.3351 L12: -0.2007 REMARK 3 L13: 0.1779 L23: -0.2228 REMARK 3 S TENSOR REMARK 3 S11: -0.0737 S12: 0.1047 S13: -0.2371 REMARK 3 S21: -0.0410 S22: -0.0290 S23: 0.1785 REMARK 3 S31: 0.1875 S32: -0.1307 S33: 0.1028 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: {C|5 - 241} REMARK 3 ORIGIN FOR THE GROUP (A): 47.4435 23.5553 -15.2433 REMARK 3 T TENSOR REMARK 3 T11: -0.0953 T22: -0.0486 REMARK 3 T33: -0.0574 T12: 0.0065 REMARK 3 T13: 0.0094 T23: 0.0710 REMARK 3 L TENSOR REMARK 3 L11: 0.9870 L22: 1.3725 REMARK 3 L33: 2.0275 L12: -0.4303 REMARK 3 L13: 0.3116 L23: 0.1422 REMARK 3 S TENSOR REMARK 3 S11: -0.0390 S12: 0.1465 S13: 0.0821 REMARK 3 S21: 0.0038 S22: -0.0621 S23: -0.1393 REMARK 3 S31: 0.1040 S32: 0.1696 S33: 0.1011 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4YQV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-MAR-15. REMARK 100 THE DEPOSITION ID IS D_1000207911. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-OCT-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9786 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46437 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.060 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.06 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.31600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1EEM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: COMPLEX WAS CONCENTRATED TO 26.2 REMARK 280 MG/ML. CRYSTALS OF THE COMPLEX GREW FROM SITTING DROPS REMARK 280 CONTAINING EQUAL VOLUMES OF PROTEIN COMPLEX AND WELL SOLUTION REMARK 280 (22.5% PEG 3350, 90 MM MES PH 6.5 AND 10 MM BACL2)., VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 93.16000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.68650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 93.16000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.68650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1830 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -16.20559 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 59.81147 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1910 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 646 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 659 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A -2 REMARK 465 ASN A -1 REMARK 465 ALA A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLY A 3 REMARK 465 GLU A 4 REMARK 465 SER B -2 REMARK 465 ASN B -1 REMARK 465 ALA B 0 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 GLY B 3 REMARK 465 GLU B 4 REMARK 465 SER C -2 REMARK 465 ASN C -1 REMARK 465 ALA C 0 REMARK 465 MET C 1 REMARK 465 SER C 2 REMARK 465 GLY C 3 REMARK 465 GLU C 4 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 11 CD CE NZ REMARK 470 LYS A 57 CG CD CE NZ REMARK 470 LYS A 65 CG CD CE NZ REMARK 470 LYS A 100 CG CD CE NZ REMARK 470 GLN A 134 CG CD OE1 NE2 REMARK 470 LYS A 136 CG CD CE NZ REMARK 470 GLU A 137 CG CD OE1 OE2 REMARK 470 TYR A 139 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 148 CG CD CE NZ REMARK 470 HIS A 195 CG ND1 CD2 CE1 NE2 REMARK 470 LEU A 216 CG CD1 CD2 REMARK 470 GLU A 219 CG CD OE1 OE2 REMARK 470 LYS A 220 CG CD CE NZ REMARK 470 LEU A 241 CG CD1 CD2 REMARK 470 LYS B 11 CD CE NZ REMARK 470 GLU B 61 CG CD OE1 OE2 REMARK 470 LYS B 65 CG CD CE NZ REMARK 470 LYS B 100 CG CD CE NZ REMARK 470 LYS B 122 CG CD CE NZ REMARK 470 LYS B 136 CG CD CE NZ REMARK 470 GLU B 219 CG CD OE1 OE2 REMARK 470 LYS B 220 CG CD CE NZ REMARK 470 LEU B 241 CG CD1 CD2 REMARK 470 LYS C 11 CD CE NZ REMARK 470 LYS C 57 CG CD CE NZ REMARK 470 LYS C 65 CG CD CE NZ REMARK 470 LYS C 100 CG CD CE NZ REMARK 470 LYS C 136 CG CD CE NZ REMARK 470 GLU C 137 CG CD OE1 OE2 REMARK 470 ASP C 138 CG OD1 OD2 REMARK 470 LYS C 148 CG CD CE NZ REMARK 470 GLU C 219 CG CD OE1 OE2 REMARK 470 LYS C 220 CG CD CE NZ REMARK 470 LEU C 241 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 85 115.23 84.03 REMARK 500 ASN B 58 57.15 -143.22 REMARK 500 GLU B 85 118.80 82.84 REMARK 500 GLN B 134 -69.28 -99.35 REMARK 500 GLU C 85 113.77 79.75 REMARK 500 GLN C 134 -98.62 -124.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 720 DISTANCE = 6.04 ANGSTROMS REMARK 525 HOH B 721 DISTANCE = 7.70 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4GG A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide 4GG B 500 and CYS B REMARK 800 32 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide 4GG C 500 and CYS C REMARK 800 32 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4YQM RELATED DB: PDB REMARK 900 RELATED ID: 4YQU RELATED DB: PDB DBREF 4YQV A 1 241 UNP P78417 GSTO1_HUMAN 1 241 DBREF 4YQV B 1 241 UNP P78417 GSTO1_HUMAN 1 241 DBREF 4YQV C 1 241 UNP P78417 GSTO1_HUMAN 1 241 SEQADV 4YQV SER A -2 UNP P78417 EXPRESSION TAG SEQADV 4YQV ASN A -1 UNP P78417 EXPRESSION TAG SEQADV 4YQV ALA A 0 UNP P78417 EXPRESSION TAG SEQADV 4YQV SER B -2 UNP P78417 EXPRESSION TAG SEQADV 4YQV ASN B -1 UNP P78417 EXPRESSION TAG SEQADV 4YQV ALA B 0 UNP P78417 EXPRESSION TAG SEQADV 4YQV SER C -2 UNP P78417 EXPRESSION TAG SEQADV 4YQV ASN C -1 UNP P78417 EXPRESSION TAG SEQADV 4YQV ALA C 0 UNP P78417 EXPRESSION TAG SEQRES 1 A 244 SER ASN ALA MET SER GLY GLU SER ALA ARG SER LEU GLY SEQRES 2 A 244 LYS GLY SER ALA PRO PRO GLY PRO VAL PRO GLU GLY SER SEQRES 3 A 244 ILE ARG ILE TYR SER MET ARG PHE CYS PRO PHE ALA GLU SEQRES 4 A 244 ARG THR ARG LEU VAL LEU LYS ALA LYS GLY ILE ARG HIS SEQRES 5 A 244 GLU VAL ILE ASN ILE ASN LEU LYS ASN LYS PRO GLU TRP SEQRES 6 A 244 PHE PHE LYS LYS ASN PRO PHE GLY LEU VAL PRO VAL LEU SEQRES 7 A 244 GLU ASN SER GLN GLY GLN LEU ILE TYR GLU SER ALA ILE SEQRES 8 A 244 THR CYS GLU TYR LEU ASP GLU ALA TYR PRO GLY LYS LYS SEQRES 9 A 244 LEU LEU PRO ASP ASP PRO TYR GLU LYS ALA CYS GLN LYS SEQRES 10 A 244 MET ILE LEU GLU LEU PHE SER LYS VAL PRO SER LEU VAL SEQRES 11 A 244 GLY SER PHE ILE ARG SER GLN ASN LYS GLU ASP TYR ALA SEQRES 12 A 244 GLY LEU LYS GLU GLU PHE ARG LYS GLU PHE THR LYS LEU SEQRES 13 A 244 GLU GLU VAL LEU THR ASN LYS LYS THR THR PHE PHE GLY SEQRES 14 A 244 GLY ASN SER ILE SER MET ILE ASP TYR LEU ILE TRP PRO SEQRES 15 A 244 TRP PHE GLU ARG LEU GLU ALA MET LYS LEU ASN GLU CYS SEQRES 16 A 244 VAL ASP HIS THR PRO LYS LEU LYS LEU TRP MET ALA ALA SEQRES 17 A 244 MET LYS GLU ASP PRO THR VAL SER ALA LEU LEU THR SER SEQRES 18 A 244 GLU LYS ASP TRP GLN GLY PHE LEU GLU LEU TYR LEU GLN SEQRES 19 A 244 ASN SER PRO GLU ALA CYS ASP TYR GLY LEU SEQRES 1 B 244 SER ASN ALA MET SER GLY GLU SER ALA ARG SER LEU GLY SEQRES 2 B 244 LYS GLY SER ALA PRO PRO GLY PRO VAL PRO GLU GLY SER SEQRES 3 B 244 ILE ARG ILE TYR SER MET ARG PHE CYS PRO PHE ALA GLU SEQRES 4 B 244 ARG THR ARG LEU VAL LEU LYS ALA LYS GLY ILE ARG HIS SEQRES 5 B 244 GLU VAL ILE ASN ILE ASN LEU LYS ASN LYS PRO GLU TRP SEQRES 6 B 244 PHE PHE LYS LYS ASN PRO PHE GLY LEU VAL PRO VAL LEU SEQRES 7 B 244 GLU ASN SER GLN GLY GLN LEU ILE TYR GLU SER ALA ILE SEQRES 8 B 244 THR CYS GLU TYR LEU ASP GLU ALA TYR PRO GLY LYS LYS SEQRES 9 B 244 LEU LEU PRO ASP ASP PRO TYR GLU LYS ALA CYS GLN LYS SEQRES 10 B 244 MET ILE LEU GLU LEU PHE SER LYS VAL PRO SER LEU VAL SEQRES 11 B 244 GLY SER PHE ILE ARG SER GLN ASN LYS GLU ASP TYR ALA SEQRES 12 B 244 GLY LEU LYS GLU GLU PHE ARG LYS GLU PHE THR LYS LEU SEQRES 13 B 244 GLU GLU VAL LEU THR ASN LYS LYS THR THR PHE PHE GLY SEQRES 14 B 244 GLY ASN SER ILE SER MET ILE ASP TYR LEU ILE TRP PRO SEQRES 15 B 244 TRP PHE GLU ARG LEU GLU ALA MET LYS LEU ASN GLU CYS SEQRES 16 B 244 VAL ASP HIS THR PRO LYS LEU LYS LEU TRP MET ALA ALA SEQRES 17 B 244 MET LYS GLU ASP PRO THR VAL SER ALA LEU LEU THR SER SEQRES 18 B 244 GLU LYS ASP TRP GLN GLY PHE LEU GLU LEU TYR LEU GLN SEQRES 19 B 244 ASN SER PRO GLU ALA CYS ASP TYR GLY LEU SEQRES 1 C 244 SER ASN ALA MET SER GLY GLU SER ALA ARG SER LEU GLY SEQRES 2 C 244 LYS GLY SER ALA PRO PRO GLY PRO VAL PRO GLU GLY SER SEQRES 3 C 244 ILE ARG ILE TYR SER MET ARG PHE CYS PRO PHE ALA GLU SEQRES 4 C 244 ARG THR ARG LEU VAL LEU LYS ALA LYS GLY ILE ARG HIS SEQRES 5 C 244 GLU VAL ILE ASN ILE ASN LEU LYS ASN LYS PRO GLU TRP SEQRES 6 C 244 PHE PHE LYS LYS ASN PRO PHE GLY LEU VAL PRO VAL LEU SEQRES 7 C 244 GLU ASN SER GLN GLY GLN LEU ILE TYR GLU SER ALA ILE SEQRES 8 C 244 THR CYS GLU TYR LEU ASP GLU ALA TYR PRO GLY LYS LYS SEQRES 9 C 244 LEU LEU PRO ASP ASP PRO TYR GLU LYS ALA CYS GLN LYS SEQRES 10 C 244 MET ILE LEU GLU LEU PHE SER LYS VAL PRO SER LEU VAL SEQRES 11 C 244 GLY SER PHE ILE ARG SER GLN ASN LYS GLU ASP TYR ALA SEQRES 12 C 244 GLY LEU LYS GLU GLU PHE ARG LYS GLU PHE THR LYS LEU SEQRES 13 C 244 GLU GLU VAL LEU THR ASN LYS LYS THR THR PHE PHE GLY SEQRES 14 C 244 GLY ASN SER ILE SER MET ILE ASP TYR LEU ILE TRP PRO SEQRES 15 C 244 TRP PHE GLU ARG LEU GLU ALA MET LYS LEU ASN GLU CYS SEQRES 16 C 244 VAL ASP HIS THR PRO LYS LEU LYS LEU TRP MET ALA ALA SEQRES 17 C 244 MET LYS GLU ASP PRO THR VAL SER ALA LEU LEU THR SER SEQRES 18 C 244 GLU LYS ASP TRP GLN GLY PHE LEU GLU LEU TYR LEU GLN SEQRES 19 C 244 ASN SER PRO GLU ALA CYS ASP TYR GLY LEU HET 4GG A 500 17 HET 4GG B 500 17 HET 4GG C 500 17 HETNAM 4GG 2-(ETHYLSULFANYL)-N-METHYL-N-[(1-PHENYL-1H-PYRAZOL-4- HETNAM 2 4GG YL)METHYL]ACETAMIDE FORMUL 4 4GG 3(C15 H19 N3 O S) FORMUL 7 HOH *405(H2 O) HELIX 1 AA1 CYS A 32 LYS A 45 1 14 HELIX 2 AA2 TRP A 62 ASN A 67 1 6 HELIX 3 AA3 GLU A 85 TYR A 97 1 13 HELIX 4 AA4 ASP A 106 SER A 121 1 16 HELIX 5 AA5 LYS A 122 ARG A 132 1 11 HELIX 6 AA6 ASN A 135 LYS A 161 1 27 HELIX 7 AA7 SER A 171 ARG A 183 1 13 HELIX 8 AA8 LEU A 189 ASP A 194 5 6 HELIX 9 AA9 THR A 196 ASP A 209 1 14 HELIX 10 AB1 ASP A 209 LEU A 215 1 7 HELIX 11 AB2 SER A 218 GLN A 231 1 14 HELIX 12 AB3 GLU A 235 TYR A 239 5 5 HELIX 13 AB4 CYS B 32 LYS B 45 1 14 HELIX 14 AB5 PRO B 60 LYS B 66 5 7 HELIX 15 AB6 GLU B 85 TYR B 97 1 13 HELIX 16 AB7 ASP B 106 SER B 121 1 16 HELIX 17 AB8 SER B 121 SER B 133 1 13 HELIX 18 AB9 ASN B 135 LYS B 161 1 27 HELIX 19 AC1 SER B 171 ARG B 183 1 13 HELIX 20 AC2 LEU B 189 ASP B 194 5 6 HELIX 21 AC3 THR B 196 GLU B 208 1 13 HELIX 22 AC4 ASP B 209 LEU B 215 1 7 HELIX 23 AC5 SER B 218 GLN B 231 1 14 HELIX 24 AC6 GLU B 235 TYR B 239 5 5 HELIX 25 AC7 CYS C 32 LYS C 45 1 14 HELIX 26 AC8 PRO C 60 LYS C 66 5 7 HELIX 27 AC9 GLU C 85 TYR C 97 1 13 HELIX 28 AD1 ASP C 106 SER C 121 1 16 HELIX 29 AD2 SER C 121 SER C 133 1 13 HELIX 30 AD3 ASN C 135 LYS C 161 1 27 HELIX 31 AD4 SER C 171 ARG C 183 1 13 HELIX 32 AD5 LEU C 189 ASP C 194 5 6 HELIX 33 AD6 THR C 196 ASP C 209 1 14 HELIX 34 AD7 ASP C 209 LEU C 215 1 7 HELIX 35 AD8 SER C 218 GLN C 231 1 14 HELIX 36 AD9 GLU C 235 TYR C 239 5 5 SHEET 1 AA1 4 HIS A 49 ASN A 53 0 SHEET 2 AA1 4 ILE A 24 SER A 28 1 N ILE A 26 O ILE A 52 SHEET 3 AA1 4 VAL A 74 ASN A 77 -1 O VAL A 74 N TYR A 27 SHEET 4 AA1 4 LEU A 82 TYR A 84 -1 O ILE A 83 N LEU A 75 SHEET 1 AA2 4 HIS B 49 ASN B 53 0 SHEET 2 AA2 4 ILE B 24 SER B 28 1 N SER B 28 O ILE B 52 SHEET 3 AA2 4 VAL B 74 ASN B 77 -1 O GLU B 76 N ARG B 25 SHEET 4 AA2 4 LEU B 82 TYR B 84 -1 O ILE B 83 N LEU B 75 SHEET 1 AA3 4 GLU C 50 ASN C 53 0 SHEET 2 AA3 4 ILE C 24 SER C 28 1 N ILE C 26 O ILE C 52 SHEET 3 AA3 4 VAL C 74 ASN C 77 -1 O VAL C 74 N TYR C 27 SHEET 4 AA3 4 LEU C 82 TYR C 84 -1 O ILE C 83 N LEU C 75 LINK SG CYS A 32 C13 4GG A 500 1555 1555 1.84 LINK SG CYS B 32 C13 4GG B 500 1555 1555 1.87 LINK SG CYS C 32 C13 4GG C 500 1555 1555 1.87 CISPEP 1 VAL A 72 PRO A 73 0 -0.52 CISPEP 2 VAL B 72 PRO B 73 0 3.03 CISPEP 3 VAL C 72 PRO C 73 0 3.54 SITE 1 AC1 10 MET A 29 PHE A 31 CYS A 32 PRO A 33 SITE 2 AC1 10 PHE A 34 LEU A 56 ILE A 131 ARG A 183 SITE 3 AC1 10 TRP A 222 PHE A 225 SITE 1 AC2 13 MET B 29 ARG B 30 PHE B 31 PRO B 33 SITE 2 AC2 13 PHE B 34 ALA B 35 GLU B 36 ILE B 131 SITE 3 AC2 13 ARG B 183 TRP B 222 PHE B 225 LEU B 226 SITE 4 AC2 13 HOH B 609 SITE 1 AC3 13 MET C 29 ARG C 30 PHE C 31 PRO C 33 SITE 2 AC3 13 PHE C 34 ALA C 35 GLU C 36 LEU C 56 SITE 3 AC3 13 ILE C 131 ARG C 183 TRP C 222 PHE C 225 SITE 4 AC3 13 HOH C 628 CRYST1 186.320 71.373 61.968 90.00 105.16 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005367 0.000000 0.001454 0.00000 SCALE2 0.000000 0.014011 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016719 0.00000